2 registered trials, newest registry update first. Showing only trials linked to Nisotirostide.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide NCT06897475 | Nisotirostide | Phase 2 | Recruiting | Eli Lilly and Company | 200 | May 2027 | Sep 14, 2026 |
| A Study of LY3457263 in Obese Participants NCT05582096 | Nisotirostide | Phase 1 | Completed | Eli Lilly and Company | 38 | Jun 8, 2023 | Jul 18, 2023 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.
